Crossmark

Dual targeting of iNOS and Src tyrosine kinase as a superior therapeutic strategy against soman-induced long-term neurotoxicity: multimodal biomarker, imaging, and neurobehavioral outcome analyses

Crossref DOI link: https://doi.org/10.1186/s40478-025-02220-8

Published Online: 2026-01-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Massey, Nyzil

Vasanthi, Suraj S.

Meyer, Christina

Rao, Nikhil S.

Thedens, Daniel R.

Wang, Chong

Kannurpatti, Sridhar

Thippeswamy, Thimmasettappa
Funding

Funding for this research was provided by:

National Institute of Health/NINDS CounterACT (U01 NS117284)
License Information

Text and Data Mining valid from 2026-01-09

Version of Record valid from 2026-02-06
More Information

Article History

Received: 7 October 2025

Accepted: 30 December 2025

First Online: 9 January 2026

Declarations

:

: The experiments were conducted per the approved protocols by the Institutional Animal Care and Use Committees (IACUC protocols: 23-114 & 24-072) and complied with the NIH ARRIVE Guidelines for the Care and Use of Laboratory Animals.

: All authors agreed to publish.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below